{"id":"NCT01190228","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV","officialTitle":"Assessment of the Memory Immune Response, Safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV and Long-Term Follow-Up","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08-25","primaryCompletion":"2010-10-29","completion":"2015-10-12","firstPosted":"2010-08-27","resultsPosted":"2017-11-08","lastUpdate":"2022-03-28"},"enrollment":454,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Japanese Encephalitis","Varicella"],"interventions":[{"type":"BIOLOGICAL","name":"JE-CV Vaccine","otherNames":["IMOJEV"]},{"type":"BIOLOGICAL","name":"Varicella Vaccine","otherNames":["OKAVAX®"]}],"arms":[{"label":"Group 1: JE-CV Vaccine Booster","type":"EXPERIMENTAL"},{"label":"Group 2: JE-CV Vaccine First Dose","type":"EXPERIMENTAL"},{"label":"Group 3: Varicella Vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"The aim of the study is to investigate the memory immune response and the yearly persistence of the immunity against Japanese Encephalitis (JE) after vaccination with Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in participants previously vaccinated with JE-CV vaccine.\n\nObjectives:\n\n* To describe JE immune status before and after JE-CV vaccination in subjects previously vaccinated with JE-CV vaccine\n* To describe the immune status before and after JE-CV vaccination in JE-naïve control subjects.\n* To describe the safety (in terms of solicited and unsolicited adverse events) of a single dose of JE-CV vaccine up to 6 months after the last vaccination.\n* To describe all related serious adverse events (SAEs) and related deaths from 6 months to 5 years after vaccination in JE-CV-primed subjects.","primaryOutcome":{"measure":"Percentage of Participants With JE Seroprotection Before and Following a Dose of Live Attenuated JE-CV","timeFrame":"Day 0 (pre-vaccination) and Day 7 and Day 28 post-vaccination","effectByArm":[{"arm":"JE-CV Booster","deltaMin":80.3,"sd":null},{"arm":"JE-CV First Dose","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"36 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Philippines"]},"refs":{"pmids":["29325161"],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":345},"commonTop":["Injection site Pain","Malaise","Fever","Headache","Upper respiratory tract infection"]}}